RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%. Following the trend, shares of Moderna (NASDAQ: MRNA) slid 31.8% in the first three months of the year. More recently, the conspicuous ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

As of April 11 at 11:42:40 AM EDT. Market Open.

As of April 10 at 11:40:01 a.m. EDT. Market Open.

As of April 11 at 1:11:04 p.m. EDT. Market Open.

As of 11 April at 2:40:12 pm GMT-4. Market open.

As of 3 April at 2:42:18 pm GMT-4. Market open.